Metformin regulates bone marrow stromal cells to accelerate bone healing in diabetic mice

  1. Yuqi Guo
  2. Jianlu Wei
  3. Chuanju Liu
  4. Xin Li  Is a corresponding author
  5. Wenbo Yan  Is a corresponding author
  1. Department of Molecular Pathobiology, New York University College of Dentistry, United States
  2. Department of Orthopedic Surgery, NYU Grossman School of Medicine, United States
  3. Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, United States
  4. Department of Urology, NYU Grossman School of Medicine, United States
6 figures and 1 additional file

Figures

Figure 1 with 2 supplements
Improved healing in closed transverse fracture.

(A) Schematic representation of the experimental design (created with BioRender.com). (B) Representative µCT images of femurs from each treatment group. (C) H&E staining of longitudinal femur sections (scale bar, 1 mm). (D) Histomorphometry analysis was performed on those H&E slides to evaluate the callus area at the fracture site from each treatment group (ANOVA, followed by Tukey’s post hoc test), Bars show mean ± SEM. N = 3–6, *p<0.05, **p<0.005.

Figure 1—figure supplement 1
Metformin’s effect on glucose levels in MKR mice.

(A) Glucose levels in WT and MKR mice throughout the 14-day PBS or metformin treatment. (B) Glucose tolerance test (GTT) after fasting post 14-day PBS or metformin treatment (N = 6, SD). If different letters are shown at a time point, they are statistically different from one another (ANOVA, p<0.05 by post hoc Tukey’s).

Figure 1—figure supplement 2
Transcript factor expressions within the femoral fracture callus tissue.

(A) Adipocyte, (B) osteoblast differentiation, and (C) chondrogenesis transcript factors expression in the callus tissue at 12 d post-fracture. (D) adipocyte, (E) osteoblast differentiation, and (F) chondrogenesis transcript factors expression in the callus tissue at 21 d post-fracture. PGC1α expression in the callus tissue at (G) 12 d and (H) 21 d post-fracture.

Improved healing in non-fixed radial fracture at two different time points (14 d and 23 d post-fracture).

(A) Schematic representation of the experimental design (created with BioRender.com). (B) Representative µCT images of mouse radiuses (top) and fracture sites (bottom) 14 d post-fracture (scale bar, 500 µm). Measured parameters (C–F) by µCT at 14 d post-fracture. (C) Percentage of callus bridging (%). (D) Bone mineral density (BMD; g/cm3). (E) Bone volume/tissue volume (BV/TV; %). (F) Trabecular thickness (Tb.Th; mm). (G) Representative µCT images of mouse radiuses (top) and fracture sites (bottom) 23 d post-fracture (scale bar, 500 µm). Measured parameters (H–K) by µCT at 23 d post-fracture. (H) Percentage of callus bridging (%). (I) BMD (g/cm3). (J) BV/TV (%). (K) Tb.Th (mm). Results of quantitative µCT data analysis (ANOVA, followed by Tukey’s post hoc test). Bars show mean ± SEM; N = 5–6.

Improved healing in drill-hole bone repair model.

(A) Schematic representation of the experimental design (created with BioRender.com). (B) Representative 3D images of mouse femurs with both exterior and interior general view at 14 d post-surgery. (C) Cross-plane images at the center of the drill site. (D) Representative 3D images within the drill site (scale bar, 100 µm). and (E, H) Results of quantitative µCT data analysis (ANOVA, followed by Tukey’s post hoc test; bars show mean ± SEM; n = 6–9, *p<0.05, **p<0.01, ***p<0.005, **** p<0.0001). (E) Bone mineral density (BMD; g/cm3). (F) Bone volume/tissue volume ratio (BV/TV; %). (G) Porosity (%). (H) Total pore space (mm3).

Metformin promotes bone formation.

(A) Representative images of calcein double labeling in cortical periosteum of the femur mid-shaft. (B) Serum P1NP level (ng/ml) from each treatment group at 14, 23, and 31 d post- femoral fracture (ANOVA, followed by Sidak’s post hoc test). Bars show mean ± SEM; N = 5–8, *p<0.05, ****p<0.0001.

Improved osteogenesis of bone marrow stromal cell (BMSC) from metformin-treated MKR mice.

(A) Primary BMSCs were isolated from animals that were treated with PBS or metformin in vivo for 14 d and were seeded at indicated density for CFU-F culture. (B) Results from quantitative analysis of colony counts measured using ImageJ. (C) Primary BMSCs from mice received 14-day treatment of PBS or metformin were plated in 6-well plates and cultured using differentiation medium and were tested for ALP activity, (D) Total ALP-positive area per well was measured using ImageJ. (E) von Kossa staining to examine mineralization. (F) Calculation of mineralized area. (G) Schematic representation of the experimental design. (H) Masson’s Trichrome staining on the ossicle sections. (I) Percentage of bone area (blue) per field was measured using ImageJ. Bars show mean ± SEM. n = 6–9, *p<0.05, **p<0.01, ***p<0.005, ****p<0.0001.

Improved chondrogenesis of bone marrow stromal cell (BMSC) from the metformin-treated MKR mice.

(A) Safranin O staining of longitudinal femur sections from femoral fractures at different time points (scale bar, 1 mm). (B) Cartilage area at fracture site was measured using ImageJ. (C) Chondrocyte pellet culture of BMSCs from the PBS- or metformin-treated animals. Micromass culture were generated by seeding 5 µl of primary BMSCs (1.6 × 107 cells/ml) in the center of 48-well plate and cultured under chondrogenic condition for 3 d (ANOVA, followed by Sidak’s post hoc test). Bars show mean ± SEM. n = 4–6, *p<0.05, **p<0.01.

Additional files

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yuqi Guo
  2. Jianlu Wei
  3. Chuanju Liu
  4. Xin Li
  5. Wenbo Yan
(2023)
Metformin regulates bone marrow stromal cells to accelerate bone healing in diabetic mice
eLife 12:e88310.
https://doi.org/10.7554/eLife.88310